Vitamin Shoppe, Inc. Completes Initial Public Offering
More News related to VSI
- Pali Research Initiates Coverage on Vitamin Shoppe (VSI) with a Buy; Solid EPS Growth Opportunity
- Vitamin Shoppe (VSI) Posts Q3 EPS of $2.04, Revs up Y/Y
- Vitamin Shoppe, Inc. Announces Fiscal Third Quarter 2009 Earnings
- Vitamin Shoppe, Inc. Completes Initial Public Offering
- Vitamin Shoppe, Inc. Announces Third Quarter 2009 Earnings Release Date and Conference Call
More News related to Press Releases
- WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
- Touring Exhibitions Sweden: ABBAWORLD To Premiere at Earls Court on 27Th January
- Stora Enso to Restart Production at Sunila Pulp Mill
- Firenze Jewels' Website Redesign Pushes Online Diamond Shopping to New Horizon
- Petaquilla Minerals Ltd.: Private Placement Financing
NORTH BERGEN, N.J.--(BUSINESS WIRE)-- Vitamin Shoppe, Inc. (NYSE: VSI) today announced the closing of its initial public offering of its common stock, which was priced on October 27 at a public offering price of $17.00 per share. In connection with the initial public offering, the underwriters exercised in full their option to purchase an additional 1,364,411 shares of common stock from the selling stockholders. As a result, a total of 10,460,488 shares were sold in the initial public offering, consisting of 7,666,667 shares of common stock sold by Vitamin Shoppe and 2,793,821 shares sold by the selling stockholders.
Vitamin Shoppe intends to use the net proceeds of approximately $121.2 million from the offering for the pro rata redemption of approximately $72.5 million of its outstanding preferred stock, the repurchase of approximately $45.2 million in aggregate principal amount of its outstanding senior secured notes, and the payment of offering-related expenses.
J.P.Morgan, BofA Merrill Lynch and Barclays Capital are acting as joint book-running managers for the offering. Piper Jaffray, Robert W. Baird & Co. and Stifel Nicolaus are the co-managers of the offering.
The public offering is being made only by means of a prospectus, copies of which may be obtained from either:
J.P.Morgan c/o Broadridge Financial Solutions 1155 Long Island Ave Edgewood, NY 11717 BofA Merrill Lynch 4 World Financial Center New York, NY 10080 Attention: Preliminary Prospectus Department Email: Prospectus.Requests@ml.com Barclays Capital c/o Broadridge Integrated Distribution Services 1155 Long Island Avenue Edgewood, NY 11717 Email: barclaysprospectus@broadridge.com
A registration statement relating to shares of the common stock of Vitamin Shoppe has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.
About Vitamin Shoppe, Inc.
Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products based in North Bergen, New Jersey. The company sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids to customers located primarily in the United States.
Source: Vitamin Shoppe, Inc.
Related Categories
Press ReleasesStocks Mentioned
-0.33Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
